Event Description
Each year, tens of millions of adults are affected by conditions such as depression, anxiety, PTSD and addiction. Employers spend between $29 and $48 billion annually just on employees who suffer from depression; even more money is spent treating other mental health conditions and addiction. Ketamine-assisted therapy is a breakthrough treatment that can help many individuals who suffer from these conditions. Attend the webinar to learn how this innovative therapy works, how it can help the estimated 6% of your workforce who are suffering from treatment-resistant depression as well as those suffering from other conditions, and how you can minimize your organization’s claims costs.
This program is only available virtually.